1Geiger J,Brich J,Honig-Liedl P,et al.Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel[J].Arterioscler Thromb Vasc Biol,1999,19(8):2007-2011
2Thebault JJ,Kieffer G,Lowe GD,et al.Tepeated-dose pharmacodynamics of clopidogrel in healthy subjects[J].Semin Thromb Hemost,1999,25(Suppl 2):S9-S14
3Thebault JJ,Kieffer G,Carious R.Single-dose pharmacodynamics of clopidogrel[J].Semin Thromb Hemost,1999,25(Suppl 2):S3-S8
5Bamford J,Sandercock P,Dennis MS,et al.Classification and natural history of clinically identifiable subtypes of cerebral infaretion[J].Lancet,1991,337(8756):1521-1526.
6Diener HC,Bogousslavsky J,Brass LM,et al.Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients(MATCH):randomised,double-blind,placebo-controlled trial[J].Lancet,2004,364(9431):331-337.
7Thebault JJ,Kiefer G,Carious R.Single-dose pharmacodynamies of clopidogrel[J].Semin Thromb Hemost,1999,25(S2):S3-S8.
8Savcic M,Hauert J,Bachmann F,et al.Clopidogrel loading dose regimens:Kinetic profile of pharmacodynamic response in healthy subjects[J].Semin Thromb Hemost,1999,25(S2):S15-S19.
9Castillo J.Deteriorating stroke:diagnostic criteria,predictors,mechanisms and treatment[J].Cerebrovasc Dis,1999,9(3):1-8.
10CAST(Chinese Acute Stroke Trial)Collaborative Group.A randomised placebo-controlled trial of early aspirin use in 20000 patients with acute ischaemic stroke(CAST)[J].Lancet,1997,349(9066):1641-1649.
